167 related articles for article (PubMed ID: 2484981)
41. Role of specific determinants in mannan of Candida albicans serotype A in adherence to human buccal epithelial cells.
Miyakawa Y; Kuribayashi T; Kagaya K; Suzuki M; Nakase T; Fukazawa Y
Infect Immun; 1992 Jun; 60(6):2493-9. PubMed ID: 1375200
[TBL] [Abstract][Full Text] [Related]
42. [Isolation, structure and biological action of yeast mannans].
Blanko FF; Deriabin VV; Pimenov AA; Bovina EV
Antibiot Med Biotekhnol; 1987 Dec; 32(12):925-37. PubMed ID: 2449864
[No Abstract] [Full Text] [Related]
43. Antigenic variability between Candida albicans blastospores isolated from healthy subjects and patients with Candida infection.
Poulain D; Tronchin G; Lefebvre B; Husson MO
Sabouraudia; 1982 Sep; 20(3):173-7. PubMed ID: 6753187
[TBL] [Abstract][Full Text] [Related]
44. A crossreactivity at the immunoglobulin E level of the cell wall mannoproteins of Candida albicans with other pathogenic Candida and airborne yeast species.
Kanbe T; Utsunomiya K; Ishiguro A
Clin Exp Allergy; 1997 Dec; 27(12):1449-57. PubMed ID: 9433941
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of an enzyme immunoassay using neoglycolipids constructed from Candida albicans oligomannosides to define the specificity of anti-mannan antibodies.
Faille C; Mackenzie DW; Michalski JC; Poulain D
Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):438-46. PubMed ID: 1425714
[TBL] [Abstract][Full Text] [Related]
46. HSP 90, yeasts and Corynebacterium jeikeium.
Matthews RC
Epidemiol Infect; 1991 Oct; 107(2):273-83. PubMed ID: 1718769
[TBL] [Abstract][Full Text] [Related]
47. Antigenic differences in the surface mannoproteins of Candida albicans as revealed by monoclonal antibodies.
Sundstrom PM; Tam MR; Nichols EJ; Kenny GE
Infect Immun; 1988 Mar; 56(3):601-6. PubMed ID: 3277915
[TBL] [Abstract][Full Text] [Related]
48. The Candida albicans phosphomannan complex in Candida-host interactions.
Cutler JE
Res Immunol; 1998; 149(4-5):299-308; discussion 507-9. PubMed ID: 9720948
[No Abstract] [Full Text] [Related]
49. Combined immunodeficiency with defective expression of HLA: modulation of an abnormal HLA synthesis and functional studies.
Lisowska-Grospierre B; Durandy A; Virelizier JL; Fischer A; Griscelli C
Birth Defects Orig Artic Ser; 1983; 19(3):87-91. PubMed ID: 6197113
[No Abstract] [Full Text] [Related]
50. Production and characterization of agglutinating monoclonal antibodies against predominant antigenic factors for Candida albicans.
Miyakawa Y; Kagaya K; Fukazawa Y; Soe G
J Clin Microbiol; 1986 May; 23(5):881-6. PubMed ID: 3519660
[TBL] [Abstract][Full Text] [Related]
51. A novel monoclonal antibody recognizing beta(1-3) glucans in intact cells of Candida and Cryptococcus.
Kondori N; Edebo L; Mattsby-Baltzer I
APMIS; 2008 Oct; 116(10):867-76. PubMed ID: 19132980
[TBL] [Abstract][Full Text] [Related]
52. The Candida albicans phospholipomannan induces in vitro production of tumour necrosis factor-alpha from human and murine macrophages.
Jouault T; Bernigaud A; Lepage G; Trinel PA; Poulain D
Immunology; 1994 Oct; 83(2):268-73. PubMed ID: 7835946
[TBL] [Abstract][Full Text] [Related]
53. Immune responsiveness of a novel peptidoglycan conjugate prepared from surface Candida immunogens: mannan and CR3-related protein.
Paulovicová E; Bystrický S; Machová E; Bujdáková H
FEMS Immunol Med Microbiol; 2008 Aug; 53(3):421-8. PubMed ID: 18625018
[TBL] [Abstract][Full Text] [Related]
54. [Determination of the specific activity of soluble Candida albicans antigens by the indirect immunofluorescence method].
Shidlovskaia NK
Tr Inst Im Pastera; 1982; 57():102-3. PubMed ID: 6189268
[No Abstract] [Full Text] [Related]
55. Immunochemical properties of soluble fractions of Candida albicans.
Alonso A; Scavini LM; Pionetti CH; Mouchian K; Rodríguez S
Medicina (B Aires); 1981; 41(5):579-86. PubMed ID: 7047975
[No Abstract] [Full Text] [Related]
56. Further studies on the immunoelectronmicroscopic localization of polysaccharide antigens on ultra-thin sections of Candida albicans.
Takamiya H; Vogt A; Batsford S; Kuttin ES; Müller J
Mykosen; 1985 Jan; 28(1):17-32. PubMed ID: 3883159
[No Abstract] [Full Text] [Related]
57. Comparative analysis of cell wall surface glycan expression in Candida albicans and Saccharomyces cerevisiae yeasts by flow cytometry.
Martínez-Esparza M; Sarazin A; Jouy N; Poulain D; Jouault T
J Immunol Methods; 2006 Jul; 314(1-2):90-102. PubMed ID: 16870206
[TBL] [Abstract][Full Text] [Related]
58. Candida albicans serotype B strains synthesize a serotype-specific phospholipomannan overexpressing a beta-1,2-linked mannotriose.
Trinel PA; Delplace F; Maes E; Zanetta JP; Mille C; Coddeville B; Jouault T; Strecker G; Poulain D
Mol Microbiol; 2005 Nov; 58(4):984-98. PubMed ID: 16262785
[TBL] [Abstract][Full Text] [Related]
59. Enolase activity associated with a C. albicans cytoplasmic antigen.
Mason AB; Brandt ME; Buckley HR
Yeast; 1989 Apr; 5 Spec No():S231-9. PubMed ID: 2665357
[No Abstract] [Full Text] [Related]
60. Sandwich enzyme-linked immunosorbent assay of D-mannans of Candida albicans NIH A-207 and NIH B-792 strains using concanavalin A and polyclonal rabbit anti-C. albicans antisera.
Tojo M; Shibata N; Osanai T; Mikami T; Suzuki M; Suzuki S
Carbohydr Res; 1991 Jun; 213():325-30. PubMed ID: 1933947
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
